NCT01647958 - The EndoGastric Solutions TEMPO Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 1, 2012

Primary Completion Date

October 1, 2015

Study Completion Date

December 1, 2017

Conditions

Gastroesophageal Reflux Disease (GERD)

Interventions

DEVICE

EsophyX System with SerosaFuse fasteners

Transoral Incisionless Fundoplication (TIF)/Transoral incisionless esophago-gastric fundoplication using the EsophyX System with SerosaFuse fasteners

DRUG

PPI

Control Arm participants will take maximum standard dose of PPI during Initial Study period

Trial Locations (1)

EndoGastric Solutions, Redmond